Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UVL1000 light therapy for energy levels
NCT02785133Completed
- Sponsor
- UVLrx Therapeutics
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by UVLrx Therapeutics. Primary endpoint: Self-reported subject energy levels at 10 weeks. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02785133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785133.